Overcoming the Challenges of AI Antibody Analysis
By Ben Holland
February 4, 2026
Cracking the molecular code
5 min read
False
By Ben Holland
February 4, 2026
Cracking the molecular code
5 min read
January 27, 2026
Collaboration addresses solid tumor manufacturing bottlenecks and accelerates advancement toward clinical trials
2 min read
January 26, 2026
Number of early-stage trials remains high, according to CGT Catapult data
1 min read
January 19, 2026
More experts share their thoughts on the next “big ideas” that they think will shape the near future of therapy developments.
10 min read
By Stephanie Vine
January 13, 2026
Are developers still underestimating the engineering sophistication required to scale advanced therapies in the real world? Alan Boyd discusses.
7 min read
December 17, 2025
New clinical results outline patient responses to a donor-derived, gene-edited cell therapy in relapsed and refractory T-cell leukemia
2 min read
By Heather Purvis
December 17, 2025
The promise of cell and gene therapy is boundless, but data silos are holding it back. Standardization, interoperability, and collaboration can move data as freely as science itself.
5 min read
By Stephanie Vine
December 11, 2025
Borrowing strategy from ancient Greece, Trogenix hides its therapeutic warriors inside tumor cells. CEO Ken Macnamara discusses how.
5 min read
December 10, 2025
Our latest news roundup reports on new data for Vertex’s exa-cel, funding for a cell therapy for breast cancer, and new technologies for manufacturing
3 min read
By Hendrik Dietz
December 5, 2025
Could a single infusion transform a patient’s own T cells into cancer-fighting machines? Researchers are betting on single-stranded DNA and lipid nanoparticles to make in vivo CAR-T a scalable reality.
3 min read
False
False
False